Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2015
Pharma News, 2015
FDA approves Keytruda for treatment of patients with metastatic non-small cell lung cancer whose tumors express PD-L1 with disease progression on or after platinum-containing chemotherapy
Merck, known as MSD outside the United States and Canada, today announced that the U.
Nobel prize for chemistry: Lindahl, Modrich and Sancar win for DNA research
Wednesday 7 October 2015.
New gene that ups Alzheimer’s risk found
Scientists, including one of Indian-origin, have have discovered an immune system gene associated with higher rates of amyloid plaque buildup.
Roche CEO: Big Data needs Big Pharma, and vice versa
Count Roche ($RHHBY) CEO Severin Schwan among those who see digital partnerships as the way Big Pharma can finally take advantage of Big Data.
Ignorance, Bliss, and the Pharmaceutical Industry
For example, destructive ignorance underlies the myth that pharmaceutical companies routinely profiteer off the sick.
Dopamine transmission mediated by D1 receptors essential for controlling movements in Parkinson's disease
Dopamine deficiency in the basal ganglia (a set of subcortical structures) causes severe motor dysfunctions, such as slowness of movements (bradykinesia), as observed in Parkinson'...
FDA Approves Alkermes’ Schizophrenia Treatment Aristada
The Food and Drug Administration on Monday approved Alkermes PLC’s schizophrenia treatment clearing the way for the Dublin-based bio pharmaceutical company to start selling the drug.
Baxalta and Momenta Announce Initiation of Pivotal Clinical Trial for M923, a Biosimilar Version of HUMIRA (adalimumab)
BANNOCKBURN, IL and CAMBRIDGE, MA, USA I October 05, 2015.
New use of existing drug could help retrieve memory
Dementia and Alzheimer's can lead to total memory loss, affecting not only the capacity to process new ideas, but also motor function.
3 scientists share Nobel Prize for medicine for work on parasitic diseases
By Holly Yan and Jethro Mullen, CNN, October 5, 2015.
Teva buys Mexican pharmaceutical co Rimsa for $2.3b
Teva Pharmaceutical Industries Ltd.
Dompé and Omega Pharma sign OTC product range marketing deal
Dompé farmaceutici and Omega Pharma, a division of Perrigo Company, have signed an agreement for the international marketing of the OTC product range of the Italian biopharmaceutical Group.
11
12
13
14
15
16
17
18
19
